ELAN
Elanco Animal Health, Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$22.42
−1.41%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- $0.20
- Revenue estimate
- $1.2B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.34
- EPS estimate
- $0.27
- Revenue actual
- $1.4B
- Revenue estimate
- $1.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -128.7%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $30
- PT range
- $26 – $33
- Analysts
- 3
2 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.27 | $0.34 | Beat 26.30% | $1.4B |
| May 6, 2026 | $0.34 | $0.40 | Beat 17.65% | $1.4B |
| Feb 24, 2026 | $0.11 | -$0.56 | Miss -604.95% | $1.1B |
| Nov 5, 2025 | $0.13 | $0.19 | Beat 46.15% | $1.1B |
| Aug 7, 2025 | $0.20 | $0.26 | Beat 30.00% | $1.2B |
| Feb 25, 2025 | $0.16 | $0.14 | Miss -12.50% | $1.0B |
| Nov 7, 2024 | $0.12 | $0.13 | Beat 8.33% | $1.0B |
| Aug 8, 2024 | $0.24 | $0.30 | Beat 25.00% | $1.2B |
| Feb 26, 2024 | $0.10 | $0.08 | Miss -20.00% | $1.0B |
| Feb 21, 2023 | $0.13 | $0.19 | Beat 46.15% | $988.0M |
| Feb 24, 2022 | $0.17 | $0.21 | Beat 23.53% | $1.1B |
| Nov 5, 2021 | $0.17 | $0.19 | Beat 11.76% | $1.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026